Rite Aid awarded Specialty Pharmacy accreditation from URAC
CAMP HILL, Pa. — Rite Aid on Tuesday announced it has been awarded Specialty Pharmacy accreditation from URAC, a Washington, D.C.-based healthcare accreditation organization that establishes quality standards for the healthcare industry.
“We are very proud to have received full accreditation as a specialty pharmacy provider from URAC,” stated Robert Thompson, Rite Aid EVP pharmacy. “Every day, Rite Aid pharmacists are committed to providing all of our patients, especially those receiving specialty pharmacy treatments, with the best care possible. This designation from URAC recognizes our efforts and is great achievement for our Specialty Pharmacy team.”
With FDA approval of more and more complex medication therapies, Rite Aid believes it is critical to have the processes in place to support these therapies and the clinical care programs to promote positive outcomes for patients. Rite Aid Specialty Pharmacy achieves this through individualized patient care plans, disease and drug education and ongoing adherence management.
“By applying for and receiving URAC accreditation, Rite Aid has demonstrated a commitment to quality healthcare,” commented URAC president and CEO Kylanne Green. “In today’s healthcare market, URAC accreditation provides a mark of distinction and we applaud Rite Aid for meeting strict quality standards and achieving URAC Specialty Pharmacy accreditation.”
Meijer rebrands its signature hunger relief program Simply Give
GRAND RAPIDS, Mich. — In an effort to increase donations to its food pantry partners, Meijer announced Tuesday that it has rebranded its signature hunger relief program, Simply Give, with the color orange to align more closely to the issue that continues to rise throughout the Midwest.
To celebrate the enhancement of its program, the Grand Rapids, Mich.-based retailer will stretch every customer’s $10 Simply Give donation further April 11 to 12. That means for every $10 donation card purchase, Meijer will contribute $20, resulting in a total $30 donation.
"Orange represents the color of hunger awareness, and we wanted Simply Give to connect more closely to the issue at hand," stated co-chairman Hank Meijer. "Thanks to the continued support and generosity of our customers, team members and pantry partners, we’ve been feeding hungry families in the communities we serve for more than five years. We believe these changes will bring more awareness to the Simply Give program, and in turn, help us give even more to our food pantry partners."
Meijer began its Simply Give program in November 2008 as a way to help restock the shelves of local food pantries throughout the Midwest.
Since then, the program has generated nearly $8 million for those food pantry partners to distribute to hungry families. And, more importantly, those meals stay local, said Janet Emerson, EVP retail operations for Meijer. "We know how important it is to our customers that their generous donations remain in their local communities," Emerson said. "That’s why each of our stores partner with a local food pantry during the Simply Give campaign."
During each Simply Give campaign, customers are encouraged to purchase $10 Simply Give donation cards that are then converted into Meijer food-only gift cards and given to the food pantry selected by the store. The Simply Give program runs three times a year; the spring campaign will run through May 12.
Although the spring campaign is seven weeks long, the opportunity for customers to get their Simply Give donations double matched will be April 11 to 12.
Customers can find the rebranded Simply Give donation cards on fixtures near the checkout, and grocery and pharmacy departments.
Diplomat to distribute Otezla for psoriatic arthritis
FLINT, Mich. — Diplomat on Monday announced that it is one of a select group of specialty pharmacies contracted by Celgene to distribute Otezla (apremilast), a new medication for the treatment of psoriatic arthritis. Otezla is an oral small-molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAMP).
Otezla was approved by the FDA on March 21, 2014, and is available in 10 mg, 20 mg and 30 mg tablets.
Per manufacturer’s instructions, patients taking Otezla should have their weight monitored regularly by a healthcare professional. If clinically significant or unexplained weight loss occurs while taking Otezla, the patient should be evaluated and discontinuation of therapy should be considered. The most common side effects experienced by patients taking Otezla were diarrhea, nausea and headache. In clinical trials, patients taking Otezla were also associated with more reports of depression compared to those patients on placebo.